Friday, 1 May 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 01 May 2026
News

Drought strikes May PBS listings

Posted 1 May 2026 PM

PBS listings have almost ground to a halt with only three additions to the scheme this month, compared to 17 in April and 12 in March.

Actor Pharmaceuticals had the biggest showing with Axhidrox listed on the PBS for primary axillary hyperhidrosis (PAHH) and Actobet listed for chronic stable plaque type psoriasis vulgaris. Both medicines were recommended at the PBAC’s November 2025 meeting.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (8)

Sales & Customer Relations (10)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (4)

Other (6)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.